Understanding Psychiatric Risks of Adolescent Cannabis Use
Adolescent cannabis use psychiatric risks are significant and differ from adult use. Teen cannabis exposure can increase the likelihood of psychosis and bipolar disorder. Understanding these risks is crucial for prevention and clinical guidance.
AEF0117 THC Interaction Trial Withdrawn: Implications for Selective CB1 Modulation
The withdrawal of the AEF0117 trial delays progress in selective CB1 receptor modulation for managing THC-related effects. This setback impacts potential pharmacological treatments for cannabis use disorder. Clinicians and patients face longer timelines…
Marijuana Use & Dangers for Adolescents & Young Adults
Marijuana use adolescent mental health risks are significant due to the brain's ongoing development into the mid-twenties. Regular cannabis use during adolescence can accelerate mental health problems requiring professional care. Understanding these…
Understanding Cannabinoid Hyperemesis Syndrome in Chronic Cannabis Users
Cannabinoid hyperemesis syndrome clinical overview reveals a paradoxical condition affecting chronic cannabis users. It causes severe nausea and vomiting, often temporarily relieved by hot showers. Understanding this syndrome is crucial for proper…
Modulating the Endocannabinoid System in Alcohol Use Disorder: A Translational Systematic Review
ECS modulation alcohol use disorder offers a novel approach targeting neurobiological mechanisms of craving and relapse. This translational review highlights cannabinoid receptor roles in alcohol dependence. ECS-targeted therapies may expand options for…
Many NC Candidates Support Medical Marijuana Legalization | Raleigh News & Observer
The North Carolina medical cannabis program is gaining political momentum as candidates across parties voice support. This program could provide legal access to cannabis therapies for patients with chronic pain, cancer, and epilepsy. Regulated access…
The Role of the Endocannabinoid System in Placebo Analgesia
The endocannabinoid system placebo analgesia plays a key role in mediating pain relief by combining expectation and cannabinoid signaling. This mechanism suggests that both pharmacological and psychological factors contribute to analgesia. Understanding…
“Mother of Cannabinoids”: The Rising Potential of CBG and CBG-A
Cannabigerol anxiety cognitive symptoms are gaining attention as potential targets for new cannabinoid therapies. Patients not responding to CBD or THC may find promise in CBG formulations. Clinical evidence is preliminary but growing in this area.
Study Links Prenatal Cannabis Exposure to Schizophrenia Risk
Emerging research on prenatal cannabis exposure schizophrenia risk reveals biological signatures in placental tissue linked to increased schizophrenia risk in offspring. The placenta mediates fetal neurodevelopment during critical brain formation…
How Prenatal THC Exposure Alters Placental Biology Linked to Schizophrenia
Emerging research highlights placental biology prenatal THC exposure as a key factor in early schizophrenia risk detection. These placental changes may influence fetal neurodevelopment through epigenetic and inflammatory pathways. Understanding placental…